Loyola is one of the nation's most active, experienced and successful transplantation centers. Our multidisciplinary approach to care allows us to collaboratively develop the best possible treatment plan for each patient. Our outcomes rank above the national average and offer our patients new hope. The only academic medical center in the Chicago suburbs, Loyola offers transplantation patients the world-class expertise and the convenience of multiple suburban locations. Our health-care providers are here to improve the life of patients by caring for them in mind, body and spirit.
Loyola's clinical researchers are recognized nationally for their pioneering cancer research and treatment programs using stem cell and bone marrow transplantation, chemotherapy, biologic response modifiers, surgery and radiation therapy. Since 1994, cancer patients have participated in more than 200 clinical trials at Loyola, allowing them to receive therapies that are not yet available at community hospitals.
More than 150 cornea transplants have been performed at Loyola since 1990.
More than 600 heart transplants have been performed since the Medicare-approved program began in March 1984. Loyola is one of the oldest and most active organ transplantation programs in the U.S. Current one-year, five-year, and 10-year survival rates are 87 percent, 70 percent and 50 percent respectively.
More than 25 heart-lung transplants have been performed at Loyola since 1986, when Loyola performed the first such organ transplant procedure in Illinois.
The Intra-Abdominal Organ Transplantation Division treats diseases of the liver and kidneys. Surgeons anticipate adding intestinal and small bowel transplantations to complete the intra-abdominal program, which already includes liver and kidney transplantation.
As part of the Intra-Abdominal Transplantation program, Loyola has performed more than 775 kidney transplantations have been performed since the program's inception in 1971. Short- and long-term graft survival rates, as well as low rejection rates in adult and pediatric recipients, are among the best in the United States.
Loyola's Intra-Abdominal Transplantation program has completed 216 liver transplantations since the first liver transplant was done in July 1, 1997. Current 90-day, one-year, and five-year patient survival rates are 94 percent, 90 percent and 78 percent respectively. Survival rates match or exceed national averages as determined by United Network for Organ Sharing (UNOS).
More than 500 lung transplantations have been performed at Loyola since 1990, making Loyola the largest lung transplantation center in Illinois and among the top organ transplantation programs in the United States. Loyola's lung transplantation specialists perform approximately 30 lung transplantations a year. Loyola is the only lung transplantation program in Illinois that is Medicare-approved. Additionally, Loyola is United Network for Organ Sharing and Blue Cross/Blue Shield approved.
For an appointment or for more information about Transplantation Services, call (888) LUHS-888.